Selective NR1/2B N-Methyl-d-aspartate Receptor Antagonists among Indole-2-carboxamides and Benzimidazole-2-carboxamides

(4-Benzylpiperidine-1-yl)-(6-hydroxy-1H-indole-2-yl)-methanone (6a) derived from (E)-1-(4-benzylpiperidin-1-yl)-3-(4-hydroxy-phenyl)-propenone (5) was identified as a potent NR2B subunit-selective antagonist of the NMDA receptor. To establish the structure−activity relationship (SAR) and to attempt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2007-03, Vol.50 (5), p.901-914
Hauptverfasser: Borza, István, Bozó, Éva, Barta-Szalai, Gizella, Kiss, Csilla, Tárkányi, Gábor, Demeter, Ádám, Gáti, Tamás, Háda, Viktor, Kolok, Sándor, Gere, Anikó, Fodor, László, Nagy, József, Galgóczy, Kornél, Magdó, Ildikó, Ágai, Béla, Fetter, József, Bertha, Ferenc, Keserü, György M, Horváth, Csilla, Farkas, Sándor, Greiner, István, Domány, György
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 914
container_issue 5
container_start_page 901
container_title Journal of medicinal chemistry
container_volume 50
creator Borza, István
Bozó, Éva
Barta-Szalai, Gizella
Kiss, Csilla
Tárkányi, Gábor
Demeter, Ádám
Gáti, Tamás
Háda, Viktor
Kolok, Sándor
Gere, Anikó
Fodor, László
Nagy, József
Galgóczy, Kornél
Magdó, Ildikó
Ágai, Béla
Fetter, József
Bertha, Ferenc
Keserü, György M
Horváth, Csilla
Farkas, Sándor
Greiner, István
Domány, György
description (4-Benzylpiperidine-1-yl)-(6-hydroxy-1H-indole-2-yl)-methanone (6a) derived from (E)-1-(4-benzylpiperidin-1-yl)-3-(4-hydroxy-phenyl)-propenone (5) was identified as a potent NR2B subunit-selective antagonist of the NMDA receptor. To establish the structure−activity relationship (SAR) and to attempt the improvement of the ADME properties of the lead, a series of compounds were prepared and tested. Several derivatives showed low nanomolar activity both in the binding and in the functional assay. In a formalin-induced hyperalgesia model in mice, 6a and (4-benzylpiperidine-1-yl)-[5(6)-hydroxy-1H-benzimidazol-2-yl]-methanone (60a) were as active as besonprodil (2) after oral administration. A CoMSIA model was developed based on binding data of a series of indole- and benzimidazole-2-carboxamides.
doi_str_mv 10.1021/jm060420k
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70221855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70221855</sourcerecordid><originalsourceid>FETCH-LOGICAL-a381t-50254dbfd6b21bdf4232cae11057565b3139dd88fded09431fec3bc69393d7693</originalsourceid><addsrcrecordid>eNpt0E1v1DAQgGELgehSOPAHUC4g9WBqj-N8HLsrCq3Cgtpy4WI59qRkm9hbOwttfz2udtU9wGlkzaOR9RLylrOPnAE_Xo2sYDmwm2dkxiUwmlcsf05mjAFQKEAckFcxrhhjgoN4SQ54CTWry2pG_lzigGbqf2O2vODHMM-W9CtOv-4HaqmOax0mPWF2gQbXkw_ZiZv0tXd9nGKmR--uszNn_YAUqNGh9Xd67C2mnbPZHN1Dn5764V_wmrzo9BDxzW4ekh-nn64WX2jz7fPZ4qShWlR8opKBzG3b2aIF3touBwFGI-dMlrKQreCitraqOouW1bngHRrRmqIWtbBlGofkw_buOvjbDcZJjX00OAzaod9EVaZEvJIywaMtNMHHGLBT69CPOtwrztRjZfVUOdl3u6ObdkS7l7usCbzfAR2NHrqgnenj3lWFBMh5cnTrUk-8e9rrcKOKUpRSXX2_VD8X0MyX541q9ne1iWrlN8Gldv_54F8mBZ_A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70221855</pqid></control><display><type>article</type><title>Selective NR1/2B N-Methyl-d-aspartate Receptor Antagonists among Indole-2-carboxamides and Benzimidazole-2-carboxamides</title><source>ACS Publications</source><source>MEDLINE</source><creator>Borza, István ; Bozó, Éva ; Barta-Szalai, Gizella ; Kiss, Csilla ; Tárkányi, Gábor ; Demeter, Ádám ; Gáti, Tamás ; Háda, Viktor ; Kolok, Sándor ; Gere, Anikó ; Fodor, László ; Nagy, József ; Galgóczy, Kornél ; Magdó, Ildikó ; Ágai, Béla ; Fetter, József ; Bertha, Ferenc ; Keserü, György M ; Horváth, Csilla ; Farkas, Sándor ; Greiner, István ; Domány, György</creator><creatorcontrib>Borza, István ; Bozó, Éva ; Barta-Szalai, Gizella ; Kiss, Csilla ; Tárkányi, Gábor ; Demeter, Ádám ; Gáti, Tamás ; Háda, Viktor ; Kolok, Sándor ; Gere, Anikó ; Fodor, László ; Nagy, József ; Galgóczy, Kornél ; Magdó, Ildikó ; Ágai, Béla ; Fetter, József ; Bertha, Ferenc ; Keserü, György M ; Horváth, Csilla ; Farkas, Sándor ; Greiner, István ; Domány, György</creatorcontrib><description>(4-Benzylpiperidine-1-yl)-(6-hydroxy-1H-indole-2-yl)-methanone (6a) derived from (E)-1-(4-benzylpiperidin-1-yl)-3-(4-hydroxy-phenyl)-propenone (5) was identified as a potent NR2B subunit-selective antagonist of the NMDA receptor. To establish the structure−activity relationship (SAR) and to attempt the improvement of the ADME properties of the lead, a series of compounds were prepared and tested. Several derivatives showed low nanomolar activity both in the binding and in the functional assay. In a formalin-induced hyperalgesia model in mice, 6a and (4-benzylpiperidine-1-yl)-[5(6)-hydroxy-1H-benzimidazol-2-yl]-methanone (60a) were as active as besonprodil (2) after oral administration. A CoMSIA model was developed based on binding data of a series of indole- and benzimidazole-2-carboxamides.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm060420k</identifier><identifier>PMID: 17290978</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Analgesics - chemical synthesis ; Analgesics - chemistry ; Analgesics - pharmacology ; Animals ; Benzimidazoles - chemical synthesis ; Benzimidazoles - chemistry ; Benzimidazoles - pharmacology ; Biological and medical sciences ; Calcium - metabolism ; Cells, Cultured ; Glutamatergic system (aspartate and other excitatory aminoacids) ; In Vitro Techniques ; Indoles - chemical synthesis ; Indoles - chemistry ; Indoles - pharmacology ; Intracellular Space - metabolism ; Male ; Medical sciences ; Mice ; Models, Molecular ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pain Measurement ; Patch-Clamp Techniques ; Pharmacology. Drug treatments ; Piperazines - chemical synthesis ; Piperazines - chemistry ; Piperazines - pharmacology ; Prosencephalon - cytology ; Prosencephalon - metabolism ; Quantitative Structure-Activity Relationship ; Radioligand Assay ; Rats ; Rats, Wistar ; Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><ispartof>Journal of medicinal chemistry, 2007-03, Vol.50 (5), p.901-914</ispartof><rights>Copyright © 2007 American Chemical Society</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a381t-50254dbfd6b21bdf4232cae11057565b3139dd88fded09431fec3bc69393d7693</citedby><cites>FETCH-LOGICAL-a381t-50254dbfd6b21bdf4232cae11057565b3139dd88fded09431fec3bc69393d7693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm060420k$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm060420k$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18652241$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17290978$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Borza, István</creatorcontrib><creatorcontrib>Bozó, Éva</creatorcontrib><creatorcontrib>Barta-Szalai, Gizella</creatorcontrib><creatorcontrib>Kiss, Csilla</creatorcontrib><creatorcontrib>Tárkányi, Gábor</creatorcontrib><creatorcontrib>Demeter, Ádám</creatorcontrib><creatorcontrib>Gáti, Tamás</creatorcontrib><creatorcontrib>Háda, Viktor</creatorcontrib><creatorcontrib>Kolok, Sándor</creatorcontrib><creatorcontrib>Gere, Anikó</creatorcontrib><creatorcontrib>Fodor, László</creatorcontrib><creatorcontrib>Nagy, József</creatorcontrib><creatorcontrib>Galgóczy, Kornél</creatorcontrib><creatorcontrib>Magdó, Ildikó</creatorcontrib><creatorcontrib>Ágai, Béla</creatorcontrib><creatorcontrib>Fetter, József</creatorcontrib><creatorcontrib>Bertha, Ferenc</creatorcontrib><creatorcontrib>Keserü, György M</creatorcontrib><creatorcontrib>Horváth, Csilla</creatorcontrib><creatorcontrib>Farkas, Sándor</creatorcontrib><creatorcontrib>Greiner, István</creatorcontrib><creatorcontrib>Domány, György</creatorcontrib><title>Selective NR1/2B N-Methyl-d-aspartate Receptor Antagonists among Indole-2-carboxamides and Benzimidazole-2-carboxamides</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>(4-Benzylpiperidine-1-yl)-(6-hydroxy-1H-indole-2-yl)-methanone (6a) derived from (E)-1-(4-benzylpiperidin-1-yl)-3-(4-hydroxy-phenyl)-propenone (5) was identified as a potent NR2B subunit-selective antagonist of the NMDA receptor. To establish the structure−activity relationship (SAR) and to attempt the improvement of the ADME properties of the lead, a series of compounds were prepared and tested. Several derivatives showed low nanomolar activity both in the binding and in the functional assay. In a formalin-induced hyperalgesia model in mice, 6a and (4-benzylpiperidine-1-yl)-[5(6)-hydroxy-1H-benzimidazol-2-yl]-methanone (60a) were as active as besonprodil (2) after oral administration. A CoMSIA model was developed based on binding data of a series of indole- and benzimidazole-2-carboxamides.</description><subject>Analgesics - chemical synthesis</subject><subject>Analgesics - chemistry</subject><subject>Analgesics - pharmacology</subject><subject>Animals</subject><subject>Benzimidazoles - chemical synthesis</subject><subject>Benzimidazoles - chemistry</subject><subject>Benzimidazoles - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Calcium - metabolism</subject><subject>Cells, Cultured</subject><subject>Glutamatergic system (aspartate and other excitatory aminoacids)</subject><subject>In Vitro Techniques</subject><subject>Indoles - chemical synthesis</subject><subject>Indoles - chemistry</subject><subject>Indoles - pharmacology</subject><subject>Intracellular Space - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Models, Molecular</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pain Measurement</subject><subject>Patch-Clamp Techniques</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperazines - chemical synthesis</subject><subject>Piperazines - chemistry</subject><subject>Piperazines - pharmacology</subject><subject>Prosencephalon - cytology</subject><subject>Prosencephalon - metabolism</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0E1v1DAQgGELgehSOPAHUC4g9WBqj-N8HLsrCq3Cgtpy4WI59qRkm9hbOwttfz2udtU9wGlkzaOR9RLylrOPnAE_Xo2sYDmwm2dkxiUwmlcsf05mjAFQKEAckFcxrhhjgoN4SQ54CTWry2pG_lzigGbqf2O2vODHMM-W9CtOv-4HaqmOax0mPWF2gQbXkw_ZiZv0tXd9nGKmR--uszNn_YAUqNGh9Xd67C2mnbPZHN1Dn5764V_wmrzo9BDxzW4ekh-nn64WX2jz7fPZ4qShWlR8opKBzG3b2aIF3touBwFGI-dMlrKQreCitraqOouW1bngHRrRmqIWtbBlGofkw_buOvjbDcZJjX00OAzaod9EVaZEvJIywaMtNMHHGLBT69CPOtwrztRjZfVUOdl3u6ObdkS7l7usCbzfAR2NHrqgnenj3lWFBMh5cnTrUk-8e9rrcKOKUpRSXX2_VD8X0MyX541q9ne1iWrlN8Gldv_54F8mBZ_A</recordid><startdate>20070308</startdate><enddate>20070308</enddate><creator>Borza, István</creator><creator>Bozó, Éva</creator><creator>Barta-Szalai, Gizella</creator><creator>Kiss, Csilla</creator><creator>Tárkányi, Gábor</creator><creator>Demeter, Ádám</creator><creator>Gáti, Tamás</creator><creator>Háda, Viktor</creator><creator>Kolok, Sándor</creator><creator>Gere, Anikó</creator><creator>Fodor, László</creator><creator>Nagy, József</creator><creator>Galgóczy, Kornél</creator><creator>Magdó, Ildikó</creator><creator>Ágai, Béla</creator><creator>Fetter, József</creator><creator>Bertha, Ferenc</creator><creator>Keserü, György M</creator><creator>Horváth, Csilla</creator><creator>Farkas, Sándor</creator><creator>Greiner, István</creator><creator>Domány, György</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070308</creationdate><title>Selective NR1/2B N-Methyl-d-aspartate Receptor Antagonists among Indole-2-carboxamides and Benzimidazole-2-carboxamides</title><author>Borza, István ; Bozó, Éva ; Barta-Szalai, Gizella ; Kiss, Csilla ; Tárkányi, Gábor ; Demeter, Ádám ; Gáti, Tamás ; Háda, Viktor ; Kolok, Sándor ; Gere, Anikó ; Fodor, László ; Nagy, József ; Galgóczy, Kornél ; Magdó, Ildikó ; Ágai, Béla ; Fetter, József ; Bertha, Ferenc ; Keserü, György M ; Horváth, Csilla ; Farkas, Sándor ; Greiner, István ; Domány, György</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a381t-50254dbfd6b21bdf4232cae11057565b3139dd88fded09431fec3bc69393d7693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Analgesics - chemical synthesis</topic><topic>Analgesics - chemistry</topic><topic>Analgesics - pharmacology</topic><topic>Animals</topic><topic>Benzimidazoles - chemical synthesis</topic><topic>Benzimidazoles - chemistry</topic><topic>Benzimidazoles - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Calcium - metabolism</topic><topic>Cells, Cultured</topic><topic>Glutamatergic system (aspartate and other excitatory aminoacids)</topic><topic>In Vitro Techniques</topic><topic>Indoles - chemical synthesis</topic><topic>Indoles - chemistry</topic><topic>Indoles - pharmacology</topic><topic>Intracellular Space - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Models, Molecular</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pain Measurement</topic><topic>Patch-Clamp Techniques</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperazines - chemical synthesis</topic><topic>Piperazines - chemistry</topic><topic>Piperazines - pharmacology</topic><topic>Prosencephalon - cytology</topic><topic>Prosencephalon - metabolism</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Borza, István</creatorcontrib><creatorcontrib>Bozó, Éva</creatorcontrib><creatorcontrib>Barta-Szalai, Gizella</creatorcontrib><creatorcontrib>Kiss, Csilla</creatorcontrib><creatorcontrib>Tárkányi, Gábor</creatorcontrib><creatorcontrib>Demeter, Ádám</creatorcontrib><creatorcontrib>Gáti, Tamás</creatorcontrib><creatorcontrib>Háda, Viktor</creatorcontrib><creatorcontrib>Kolok, Sándor</creatorcontrib><creatorcontrib>Gere, Anikó</creatorcontrib><creatorcontrib>Fodor, László</creatorcontrib><creatorcontrib>Nagy, József</creatorcontrib><creatorcontrib>Galgóczy, Kornél</creatorcontrib><creatorcontrib>Magdó, Ildikó</creatorcontrib><creatorcontrib>Ágai, Béla</creatorcontrib><creatorcontrib>Fetter, József</creatorcontrib><creatorcontrib>Bertha, Ferenc</creatorcontrib><creatorcontrib>Keserü, György M</creatorcontrib><creatorcontrib>Horváth, Csilla</creatorcontrib><creatorcontrib>Farkas, Sándor</creatorcontrib><creatorcontrib>Greiner, István</creatorcontrib><creatorcontrib>Domány, György</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Borza, István</au><au>Bozó, Éva</au><au>Barta-Szalai, Gizella</au><au>Kiss, Csilla</au><au>Tárkányi, Gábor</au><au>Demeter, Ádám</au><au>Gáti, Tamás</au><au>Háda, Viktor</au><au>Kolok, Sándor</au><au>Gere, Anikó</au><au>Fodor, László</au><au>Nagy, József</au><au>Galgóczy, Kornél</au><au>Magdó, Ildikó</au><au>Ágai, Béla</au><au>Fetter, József</au><au>Bertha, Ferenc</au><au>Keserü, György M</au><au>Horváth, Csilla</au><au>Farkas, Sándor</au><au>Greiner, István</au><au>Domány, György</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective NR1/2B N-Methyl-d-aspartate Receptor Antagonists among Indole-2-carboxamides and Benzimidazole-2-carboxamides</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2007-03-08</date><risdate>2007</risdate><volume>50</volume><issue>5</issue><spage>901</spage><epage>914</epage><pages>901-914</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>(4-Benzylpiperidine-1-yl)-(6-hydroxy-1H-indole-2-yl)-methanone (6a) derived from (E)-1-(4-benzylpiperidin-1-yl)-3-(4-hydroxy-phenyl)-propenone (5) was identified as a potent NR2B subunit-selective antagonist of the NMDA receptor. To establish the structure−activity relationship (SAR) and to attempt the improvement of the ADME properties of the lead, a series of compounds were prepared and tested. Several derivatives showed low nanomolar activity both in the binding and in the functional assay. In a formalin-induced hyperalgesia model in mice, 6a and (4-benzylpiperidine-1-yl)-[5(6)-hydroxy-1H-benzimidazol-2-yl]-methanone (60a) were as active as besonprodil (2) after oral administration. A CoMSIA model was developed based on binding data of a series of indole- and benzimidazole-2-carboxamides.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>17290978</pmid><doi>10.1021/jm060420k</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2007-03, Vol.50 (5), p.901-914
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_70221855
source ACS Publications; MEDLINE
subjects Analgesics - chemical synthesis
Analgesics - chemistry
Analgesics - pharmacology
Animals
Benzimidazoles - chemical synthesis
Benzimidazoles - chemistry
Benzimidazoles - pharmacology
Biological and medical sciences
Calcium - metabolism
Cells, Cultured
Glutamatergic system (aspartate and other excitatory aminoacids)
In Vitro Techniques
Indoles - chemical synthesis
Indoles - chemistry
Indoles - pharmacology
Intracellular Space - metabolism
Male
Medical sciences
Mice
Models, Molecular
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pain Measurement
Patch-Clamp Techniques
Pharmacology. Drug treatments
Piperazines - chemical synthesis
Piperazines - chemistry
Piperazines - pharmacology
Prosencephalon - cytology
Prosencephalon - metabolism
Quantitative Structure-Activity Relationship
Radioligand Assay
Rats
Rats, Wistar
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
title Selective NR1/2B N-Methyl-d-aspartate Receptor Antagonists among Indole-2-carboxamides and Benzimidazole-2-carboxamides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T02%3A55%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20NR1/2B%20N-Methyl-d-aspartate%20Receptor%20Antagonists%20among%20Indole-2-carboxamides%20and%20Benzimidazole-2-carboxamides&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Borza,%20Istv%C3%A1n&rft.date=2007-03-08&rft.volume=50&rft.issue=5&rft.spage=901&rft.epage=914&rft.pages=901-914&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm060420k&rft_dat=%3Cproquest_cross%3E70221855%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70221855&rft_id=info:pmid/17290978&rfr_iscdi=true